Valeo Pharma Inc (OTCPK:VPHIF)
$ 0.0469 0 (0%) Market Cap: 526,000.00 Enterprise Value: 48.46 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2020 Valeo Pharma Inc Earnings Call Transcript

Feb 25, 2021 / 01:30PM GMT
Release Date Price: $0.7842 (-7.35%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Valeo Pharma Inc. fourth-quarter and year-end results conference call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Frederic Dumais, Director of Investor Relations. Thank you. Please go ahead, sir.

Frederic Dumais
Valeo Pharma Inc. - Director, Communications & IR

Thank you, operator. Present with me on the call today are Steve Saviuk, CEO of the company; and Luc Mainville, Senior VP and CFO of the company. Before we begin our fourth-quarter and year-end 2020 results and highlights conference call, I would like to remind everyone that this conference call may contain certain forward-looking statements regarding the company's expectations for future events.

Such expectations are based on certain assumptions that are founded on currently available information. If these assumptions prove incorrect, actual results may differ materially from those contemplated by the forward-looking statements contained in this conference call. The company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot